Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:18 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 15,643 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Activities. Clear all

Conditions: Bipolar Disorder
Interventions: Weekly review, No weekly review; Behavioral · Other
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Ann Arbor, Michigan • Madison, Wisconsin

Conditions: Falls, Alzheimer's Disease
Interventions: Wii-Fit intervention, Walking; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 60 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Glioblastoma
Interventions: Cognitive Assessment, Blood Collection, Bioenergetic Profiling; Procedure · Diagnostic Test
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: End Stage Renal Disease
Interventions: Motivational interviewing; Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Interventions: Ibrutinib, HD- Methotrexate (MTX), Rituximab + HD- Methotrexate (MTX), procarbazine; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 93 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Gait, Unsteady
Interventions: Strength training, Endurance training, Flexibility training, Task Specific timing and coordination training, Physical activity behavioral intervention; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Anterior Cruciate Ligament Reconstruction
Interventions: Plyometric Exercise; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 15 Years to 30 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Disorder of Endocrine Ovary, Hypersecretion; Cortisol, Metabolic Disturbance, Stress, Psychological
Interventions: Cognitive behavior therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2003
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fibromyalgia
Interventions: Exercise; Other
Lead sponsor: Marquette University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 99 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Substance-Related Disorders
Interventions: Behavior Therapy; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: Up to 99 Years
Enrollment: 440 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2003
U.S. locations: 11
States / cities: Los Angeles, California • Alamosa, Colorado • Littleton, Colorado + 7 more

Conditions: Breast Cancer
Interventions: [11C]Martinostat, MR-PET scanner; Drug · Device
Lead sponsor: Christine Elizabeth Edmonds; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Dose escalation followed by treatment with MTD; Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Aurora, Colorado • Boston, Massachusetts

Conditions: Pregnancy Related
Interventions: Wearable Activity Tracker; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Depression, Anxiety and Fear
Interventions: transcranial direct current stimulation; Device
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 65 Years
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Cancer, Breast Cancer
Interventions: Resistance Training with Cardio, Resistance Training with Conditioning; Behavioral
Lead sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute); Other
Eligibility: 20 Years to 89 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: Semaglutide, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 902 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 28
States / cities: Anniston, Alabama • Fresno, California • San Diego, California + 22 more

Conditions: Metastatic Melanoma
Interventions: Tumor Infiltrating Lymphocytes (TIL); Biological
Lead sponsor: Saint John's Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Diabetes
Interventions: Not listed
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 1,837 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Performance Enhancement
Interventions: Transcranial direct current stimulation; Device
Lead sponsor: United States Army Aeromedical Research Laboratory; Federal
Eligibility: 18 Years to 40 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Fort Rucker, Alabama

Conditions: Fibromyalgia
Interventions: Guided Imagery; Other
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Solid Tumors
Interventions: Avelumab; Drug
Lead sponsor: EMD Serono Research & Development Institute, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,756 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 53
States / cities: Goodyear, Arizona • Scottsdale, Arizona • Rogers, Arkansas + 45 more

Conditions: Substance Use
Interventions: Rural curriculum, Classic curriculum; Other
Lead sponsor: Penn State University; Other
Eligibility: 11 Years to 15 Years
Enrollment: 2,827 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Psoriasis
Interventions: Mindfulness-Based Stress Reduction, Living Well; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Overweight
Interventions: Not listed
Lead sponsor: The University of Tennessee, Knoxville; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Knoxville, Tennessee

Search by objective public record fields.

Modeling Mood Course to Detect Markers of Effective Adaptive Interventions

Wii-fit for Activity, Balance and Gait in Assisted Living

Bioenergetic Profiling and Cognition in GBM Patients

Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence

Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central Nervous System Lymphoma (SCNSL)

Task Specific Timing and Coordination Exercise to Improve Mobility in Older Adults: Program to Improve Mobility in Aging

Anterior Cruciate Ligament Reconstruction and Plyometric Exercise

Pathogenesis of Functional Hypothalamic Amenorrhea

Influence of Exercise Type, Pain Mechanisms, and Biopsychosocial Contributions to Pain Relief in Those With Fibromyalgia

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics - 1

Imaging With [11C]Martinostat in Breast Cancer

A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M Mutations

Assessing the Use of Wearable Activity Trackers in a Pregnancy Cohort

Frontal Stimulation to Modulate Threat Sensitivity in Anxious Depression

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity

A Study Using Tumor-Reactive Autologous Tumor Infiltrating Lymphocytes (TIL) in Metastatic Melanomas

Emory Latino Diabetes Education Program

Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance

Study to Explore the Relationships Among Immunity and Stress and the Symptoms of Fatigue, Pain, and Mood Following Guided Imagery in Women With Fibromyalgia

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Adaptation Processes in School-Based Substance Abuse Programs

Improving Psoriasis Through Health and Well-Being

Variety of Physical Activity in Normal to Overweight Adults Who Are Regularly Active